Independent Certificates of Analysis aggregated from public lab results. Not affiliated with or paid by HK Peptides.
| Compound | CoAs | Avg purity | Latest |
|---|---|---|---|
| Retatrutide | 144 | 99.78% | Sep 24, 2026 |
| Tirzepatide | 133 | 99.56% | Sep 24, 2026 |
| GHK-Cu | 51 | 99.87% | Sep 24, 2026 |
| Tesamorelin | 35 | 99.41% | Sep 24, 2026 |
| BPC-157 | 22 | 99.66% | Sep 9, 2026 |
| Ipamorelin | 13 | 98.21% | Feb 26, 2026 |
| Melanotan II | 12 | 99.67% | Jul 9, 2026 |
| Cagrilintide | 11 | 98.96% | Aug 28, 2026 |
| Semaglutide | 10 | 99.7% | Jun 1, 2026 |
| CJC-1295 No DAC | 8 | 98.57% | Mar 10, 2026 |
| PT-141 | 7 | 99.81% | Mar 10, 2026 |
| TB-500 | 7 | 98.38% | Sep 10, 2026 |
| Sermorelin | 6 | 99.08% | Sep 4, 2026 |
| TB-500 Thymosin Beta-4 | 3 | 98.94% | Feb 26, 2026 |
| CJC-1295 DAC | 2 | 99.95% | Jan 26, 2026 |
| Compound | Batch | Purity | Lab | Tested | |
|---|---|---|---|---|---|
| GHK-Cu | n/a | 99.9% | Lab E | Sep 24, 2026 | verify |
| Tirzepatide | n/a | n/a | Lab E | Sep 24, 2026 | verify |
| Tirzepatide | n/a | 75.9% | Lab L | Sep 24, 2026 | verify |
| Tesamorelin | n/a | 99.9% | Lab E | Sep 24, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Sep 24, 2026 | verify |
| Retatrutide | 2381089-83-2 | 99.9% | Lab E | Sep 17, 2026 | verify |
| GHK-Cu | 49557-75-7 | 99.9% | Lab E | Sep 15, 2026 | verify |
| Retatrutide | 43026 | 99.8% | Lab G | Sep 14, 2026 | verify |
| TB-500 | n/a | 98% | Lab E | Sep 10, 2026 | verify |
| BPC-157 | n/a | 99.9% | Lab E | Sep 9, 2026 | verify |
| Retatrutide | 2381089-83-2 | n/a | Lab E | Sep 9, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Sep 9, 2026 | verify |
| Sermorelin | n/a | n/a | Lab E | Sep 4, 2026 | verify |
| Tirzepatide | n/a | n/a | Lab G | Aug 28, 2026 | verify |
| Tirzepatide | n/a | n/a | Lab G | Aug 28, 2026 | verify |
| Tirzepatide | n/a | n/a | Lab G | Aug 28, 2026 | verify |
| Tirzepatide | n/a | n/a | Lab G | Aug 28, 2026 | verify |
| Cagrilintide | n/a | n/a | Lab G | Aug 28, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Aug 26, 2026 | verify |
| GHK-Cu | n/a | 99.9% | Lab E | Aug 26, 2026 | verify |
| Retatrutide | RT20/260514 | 99.9% | Lab E | Aug 26, 2026 | verify |
| Tesamorelin | n/a | 99.9% | Lab E | Aug 26, 2026 | verify |
| Tirzepatide | n/a | n/a | Lab E | Aug 26, 2026 | verify |
| Retatrutide | RT1002 | 99.9% | Lab E | Aug 13, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Aug 12, 2026 | verify |
Showing 25 most recent of 464. Search the full database on the CoA page.
Sell or represent HK Peptides? Link your customers to this page with the badge below. Free, no signup. The badge and counts update as new lab results land.
<a href="https://ascendpeptide.org/coa/vendor/hk-peptides/" rel="noopener"> <img src="https://ascendpeptide.org/coa/badge/hk-peptides.svg" alt="HK Peptides: lab tested, 464 CoAs on file at ASCEND Peptide" width="230" height="54"> </a>
Data comes from publicly posted third-party lab certificates (Janoshik, MZ Biolabs, and others) and community submissions. Purity figures are as reported by the testing lab for the specific batch tested; they are not a guarantee of any other batch. For research and informational purposes only.